Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin

BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.

Saved in:
Bibliographic Details
Main Authors: Shaun K Morris, Upton D Allen, Sumit Gupta, Susan E Richardson
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2012/957973
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558906579091456
author Shaun K Morris
Upton D Allen
Sumit Gupta
Susan E Richardson
author_facet Shaun K Morris
Upton D Allen
Sumit Gupta
Susan E Richardson
author_sort Shaun K Morris
collection DOAJ
description BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.
format Article
id doaj-art-f8b7c4e526224fccb165d2307bd315cf
institution Kabale University
issn 1712-9532
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-f8b7c4e526224fccb165d2307bd315cf2025-02-03T01:31:18ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-0123417918210.1155/2012/957973Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving CaspofunginShaun K Morris0Upton D Allen1Sumit Gupta2Susan E Richardson3Division of Infectious Diseases, Toronto, Ontario, CanadaDivision of Infectious Diseases, Toronto, Ontario, CanadaDivision of Haematology and Oncology, Department of Pediatrics, Toronto, Ontario, CanadaDivision of Microbiology, The Hospital for Sick Children, Toronto, Ontario, CanadaBACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.http://dx.doi.org/10.1155/2012/957973
spellingShingle Shaun K Morris
Upton D Allen
Sumit Gupta
Susan E Richardson
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
Canadian Journal of Infectious Diseases and Medical Microbiology
title Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_full Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_fullStr Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_full_unstemmed Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_short Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_sort breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin
url http://dx.doi.org/10.1155/2012/957973
work_keys_str_mv AT shaunkmorris breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
AT uptondallen breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
AT sumitgupta breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
AT susanerichardson breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin